Abattis Bioceuticals Corp. (ATTBF)

[guay]

New Science Advisor and Comptroller Appointment to Abattis

VANCOUVER, BC / ACCESSWIRE / September 27, 2016 / Abattis Bioceuticals Corp. (OTCQX: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the appointment of Dr. Shuang Xie as its newest Science and Technology Advisor. Dr. Xie graduated from Zhejiang University in 1987 and Queen's University in 1993. Dr. Xie has been widely published and holds more than 20 patents. She has assisted companies globally in assessing project risk, securing financing, and has undertaken numerous project management mandates. Dr. Xie is a founding partner of privately-held Efilcon Corp., a leading developer and producer of extraction technologies and systems and has assisted a number of manufacturers to carry out project assessment, financing, extraction equipment set up, and extraction plant construction. She is currently appointed as overseas talent for the Chinese government and an expert consultant for Zhejiang University Innovation Research Institute.

Source: http://www.otcmarkets.com/news/otc-market-headline?id=613366